| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 2.34e-07 | 3 | 124 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 2.32e-06 | 5 | 124 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 2.32e-06 | 5 | 124 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 CHRNA7 KCNH3 SLC6A1 PKD1 SLC2A13 ASIC4 TMEM109 CHRFAM7A SLC39A5 SLC4A11 | 1.60e-05 | 664 | 124 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 SLC25A6 SLC46A1 MFSD4B SLC6A1 SLC2A13 SLC39A5 SLC4A11 | 1.62e-05 | 296 | 124 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 3.72e-05 | 11 | 124 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 SLC25A6 ABCC9 SLC46A1 MFSD4B AQP5 SLC2A2 CHRNA7 KCNH3 SLC6A1 PKD1 SLC2A13 ASIC4 TMEM109 CHRFAM7A SLC39A5 ABCC10 SLC4A11 | 3.85e-05 | 1180 | 124 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | symporter activity | 4.24e-05 | 150 | 124 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 SLC25A6 ABCC9 SLC46A1 MFSD4B SLC6A1 SLC2A13 SLC39A5 ABCC10 SLC4A11 | 4.26e-05 | 477 | 124 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC25A18 SLC25A4 SLC25A5 SLC25A6 ABCC9 SLC46A1 MFSD4B AQP5 SLC2A2 CHRNA7 KCNH3 SLC6A1 CLN3 PKD1 SLC2A13 ASIC4 TMEM109 CHRFAM7A SLC39A5 ABCC10 SLC4A11 | 4.29e-05 | 1289 | 124 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 AQP5 CHRNA7 KCNH3 SLC6A1 PKD1 SLC2A13 ASIC4 SLC39A5 ABCC10 SLC4A11 | 7.28e-05 | 758 | 124 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 8.09e-05 | 14 | 124 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC2A2 SLC6A1 SLC39A5 SLC4A11 | 9.07e-05 | 293 | 124 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 CHRNA7 KCNH3 SLC6A1 PKD1 SLC2A13 ASIC4 TMEM109 CHRFAM7A SLC39A5 SLC4A11 | 1.20e-04 | 793 | 124 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 CHRNA7 KCNH3 SLC6A1 PKD1 SLC2A13 ASIC4 SLC39A5 SLC4A11 | 1.44e-04 | 627 | 124 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.45e-04 | 43 | 124 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | toxic substance binding | 1.78e-04 | 18 | 124 | 3 | GO:0015643 | |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 2.06e-04 | 47 | 124 | 4 | GO:0016790 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 3.78e-04 | 5 | 124 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 3.78e-04 | 5 | 124 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 3.78e-04 | 23 | 124 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 4.05e-04 | 56 | 124 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 4.34e-04 | 57 | 124 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 4.86e-04 | 25 | 124 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 5.47e-04 | 26 | 124 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 6.13e-04 | 27 | 124 | 3 | GO:0047617 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 6.84e-04 | 28 | 124 | 3 | GO:0016289 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 7.59e-04 | 29 | 124 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors | 8.40e-04 | 30 | 124 | 3 | GO:0016645 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 8.85e-04 | 119 | 124 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 1.11e-03 | 33 | 124 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.15e-03 | 188 | 124 | 6 | GO:0015078 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.37e-03 | 343 | 124 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.67e-03 | 10 | 124 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 1.67e-03 | 10 | 124 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.81e-03 | 39 | 124 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 2.03e-03 | 11 | 124 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 2.85e-03 | 13 | 124 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.96e-03 | 227 | 124 | 6 | GO:0051015 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 3.00e-03 | 157 | 124 | 5 | GO:0052689 | |
| GeneOntologyMolecularFunction | vitamin binding | 3.34e-03 | 161 | 124 | 5 | GO:0019842 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 3.81e-03 | 15 | 124 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 4.34e-03 | 16 | 124 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 4.89e-03 | 17 | 124 | 2 | GO:0052816 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 4.89e-03 | 17 | 124 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 5.48e-03 | 18 | 124 | 2 | GO:0016646 | |
| GeneOntologyMolecularFunction | channel activity | 5.51e-03 | 525 | 124 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.58e-03 | 526 | 124 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 5.90e-03 | 59 | 124 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 5.90e-03 | 59 | 124 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | water transmembrane transporter activity | 6.76e-03 | 20 | 124 | 2 | GO:0005372 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid metabolic process | 1.88e-06 | 35 | 122 | 5 | GO:0000038 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 2.00e-06 | 5 | 122 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | SDSL PTGES2 MRI1 ACAA1 ETFDH ABCC9 ACOT1 SLC46A1 ACOT4 GGT7 ICMT CLN3 TPH2 LYPLA1 ACOT2 HSD17B4 PYCR2 QDPR ABCC10 | 1.05e-05 | 1035 | 122 | 19 | GO:0019752 |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 1.11e-05 | 8 | 122 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | SDSL PTGES2 MRI1 ACAA1 ETFDH ABCC9 ACOT1 SLC46A1 ACOT4 GGT7 ICMT CLN3 TPH2 LYPLA1 ACOT2 HSD17B4 PYCR2 QDPR ABCC10 | 1.43e-05 | 1058 | 122 | 19 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | SDSL PTGES2 MRI1 ACAA1 ETFDH ABCC9 ACOT1 SLC46A1 ACOT4 GGT7 ICMT CLN3 TPH2 LYPLA1 ACOT2 HSD17B4 PYCR2 QDPR ABCC10 | 1.54e-05 | 1064 | 122 | 19 | GO:0006082 |
| GeneOntologyBiologicalProcess | regulation of heme biosynthetic process | 1.65e-05 | 9 | 122 | 3 | GO:0070453 | |
| GeneOntologyBiologicalProcess | regulation of tetrapyrrole biosynthetic process | 1.65e-05 | 9 | 122 | 3 | GO:1901463 | |
| GeneOntologyBiologicalProcess | regulation of tetrapyrrole metabolic process | 2.35e-05 | 10 | 122 | 3 | GO:1901401 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 3.47e-05 | 2 | 122 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | saturated monocarboxylic acid metabolic process | 3.47e-05 | 2 | 122 | 2 | GO:0032788 | |
| GeneOntologyBiologicalProcess | unsaturated monocarboxylic acid metabolic process | 3.47e-05 | 2 | 122 | 2 | GO:0032789 | |
| GeneOntologyBiologicalProcess | ADP transport | 4.27e-05 | 12 | 122 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A18 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC2A2 SLC6A1 CLN3 LYPLA1 SLC39A5 ABCC10 SLC4A11 | 5.57e-05 | 515 | 122 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 8.27e-05 | 75 | 122 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 8.72e-05 | 15 | 122 | 3 | GO:0003183 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 8.72e-05 | 15 | 122 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA catabolic process | 1.04e-04 | 3 | 122 | 2 | GO:0036116 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 1.04e-04 | 3 | 122 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | mitral valve development | 1.07e-04 | 16 | 122 | 3 | GO:0003174 | |
| GeneOntologyBiologicalProcess | associative learning | 1.24e-04 | 130 | 122 | 6 | GO:0008306 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.34e-04 | 83 | 122 | 5 | GO:0060976 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT3 KRT5 FLNC NRAP DBNL NCKAP5 CLASP2 CHRNA7 ARHGEF10L NEFH KRT71 KRT77 FSCN2 KBTBD13 CHRFAM7A FOXC1 | 1.66e-04 | 957 | 122 | 16 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of response to oxidative stress | 1.83e-04 | 19 | 122 | 3 | GO:1902883 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 2.07e-04 | 4 | 122 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 2.21e-04 | 205 | 122 | 7 | GO:0006839 | |
| GeneOntologyBiologicalProcess | amide metabolic process | NAGLU ACOT1 SLC46A1 ACOT4 CHRNA7 GGT7 ACOT2 SLC2A13 HSD17B4 CHRFAM7A CTSZ | 2.29e-04 | 511 | 122 | 11 | GO:0043603 |
| GeneOntologyBiologicalProcess | learning | 2.71e-04 | 212 | 122 | 7 | GO:0007612 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 2.73e-04 | 53 | 122 | 4 | GO:0044273 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 2.91e-04 | 284 | 122 | 8 | GO:0009913 | |
| GeneOntologyBiologicalProcess | heme metabolic process | 2.93e-04 | 54 | 122 | 4 | GO:0042168 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.06e-04 | 99 | 122 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | DEAF1 NAGLU GATA4 CLASP2 PLXND1 SEMA4C MEGF8 KRT71 PKD1 DCHS1 SMARCA4 CTSZ | 3.09e-04 | 619 | 122 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.21e-04 | 100 | 122 | 5 | GO:0045103 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta formation | 3.28e-04 | 23 | 122 | 3 | GO:1902004 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 3.28e-04 | 23 | 122 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 3.28e-04 | 23 | 122 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein metabolic process | 3.36e-04 | 101 | 122 | 5 | GO:0042982 | |
| GeneOntologyBiologicalProcess | mitral valve formation | 3.43e-04 | 5 | 122 | 2 | GO:0003192 | |
| GeneOntologyBiologicalProcess | sensory processing | 3.43e-04 | 5 | 122 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.73e-04 | 24 | 122 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | epithelium development | KRT3 KRT5 DEAF1 NAGLU GATA4 CLASP2 PLXND1 KEAP1 GFI1 SEMA4C MEGF8 KRT71 KRT77 PKD1 DCHS1 SMARCA4 HSD17B4 CTSZ FOXC1 MAF | 3.80e-04 | 1469 | 122 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | KRT5 DEAF1 METRNL GATA4 ABCC9 ACOT1 GPR88 AQP5 GFI1 CHRNA7 HPN CLN3 PKD1 PYGM RIC8A ACOT2 TMEM109 CHRFAM7A SLC4A11 | 3.97e-04 | 1361 | 122 | 19 | GO:0009628 |
| GeneOntologyBiologicalProcess | cellular catabolic process | SDSL ACAA1 SLC25A4 SLC25A5 NAGLU ETFDH GATA4 ACOT1 KEAP1 ACOT4 GGT7 CLN3 PRDX3 LYPLA1 ACOT2 WDFY3 HSD17B4 QDPR | 4.09e-04 | 1253 | 122 | 18 | GO:0044248 |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 4.11e-04 | 377 | 122 | 9 | GO:0062197 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 4.75e-04 | 26 | 122 | 3 | GO:1905709 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | DEAF1 NAGLU GATA4 CLASP2 PLXND1 SEMA4C MEGF8 KRT71 PKD1 DCHS1 SMARCA4 CTSZ FOXC1 | 5.03e-04 | 750 | 122 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 5.12e-04 | 6 | 122 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | adenine transport | 5.12e-04 | 6 | 122 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound metabolic process | 5.30e-04 | 63 | 122 | 4 | GO:0006778 | |
| GeneOntologyBiologicalProcess | heart development | NRAP SLC25A4 SPEG NAGLU GATA4 ABCC9 PLXND1 TENM4 MEGF8 PKD1 DCHS1 SMARCA4 FOXC1 | 5.48e-04 | 757 | 122 | 13 | GO:0007507 |
| GeneOntologyBiologicalProcess | atrioventricular valve morphogenesis | 5.94e-04 | 28 | 122 | 3 | GO:0003181 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 6.54e-04 | 321 | 122 | 8 | GO:0003007 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein catabolic process | 6.59e-04 | 29 | 122 | 3 | GO:1902993 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 7.43e-04 | 251 | 122 | 7 | GO:1901605 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 7.96e-04 | 122 | 122 | 5 | GO:0055013 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 8.04e-04 | 31 | 122 | 3 | GO:1901679 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 8.57e-04 | 124 | 122 | 5 | GO:0001676 | |
| GeneOntologyBiologicalProcess | atrioventricular valve development | 8.83e-04 | 32 | 122 | 3 | GO:0003171 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 CHRNA7 KCNH3 SLC6A1 HPN PKD1 ASIC4 TMEM109 CHRFAM7A SLC39A5 ABCC10 SLC4A11 | 8.88e-04 | 1115 | 122 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 9.17e-04 | 189 | 122 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 9.26e-04 | 73 | 122 | 4 | GO:0033013 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein catabolic process | 9.26e-04 | 73 | 122 | 4 | GO:0042987 | |
| GeneOntologyBiologicalProcess | response to disaccharide | 9.49e-04 | 8 | 122 | 2 | GO:0034285 | |
| GeneOntologyBiologicalProcess | fatty-acyl-CoA catabolic process | 9.49e-04 | 8 | 122 | 2 | GO:0036115 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 9.49e-04 | 8 | 122 | 2 | GO:0003025 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 9.68e-04 | 33 | 122 | 3 | GO:0097345 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic potentiation | 1.06e-03 | 34 | 122 | 3 | GO:1900273 | |
| GeneOntologyBiologicalProcess | heme biosynthetic process | 1.06e-03 | 34 | 122 | 3 | GO:0006783 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | DEAF1 NAGLU GATA4 CLASP2 GFI1 SEMA4C TENM4 MEGF8 HPN SMARCA4 RIC8A FOXC1 | 1.07e-03 | 713 | 122 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 1.13e-03 | 77 | 122 | 4 | GO:1901607 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 1.13e-03 | 132 | 122 | 5 | GO:0055006 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 1.15e-03 | 35 | 122 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | glycogen catabolic process | 1.15e-03 | 35 | 122 | 3 | GO:0005980 | |
| GeneOntologyBiologicalProcess | artery development | 1.17e-03 | 133 | 122 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | atrioventricular valve formation | 1.22e-03 | 9 | 122 | 2 | GO:0003190 | |
| GeneOntologyBiologicalProcess | positive regulation of CoA-transferase activity | 1.22e-03 | 9 | 122 | 2 | GO:1905920 | |
| GeneOntologyBiologicalProcess | glucan catabolic process | 1.25e-03 | 36 | 122 | 3 | GO:0009251 | |
| GeneOntologyBiologicalProcess | aorta development | 1.30e-03 | 80 | 122 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 MFSD4B CHRNA7 KCNH3 SLC6A1 HPN PKD1 ASIC4 TMEM109 CHRFAM7A SLC39A5 SLC4A11 | 1.31e-03 | 1157 | 122 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 1.35e-03 | 37 | 122 | 3 | GO:0034250 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC25A18 SLC25A4 SLC25A5 ABCC9 SLC46A1 CHRNA7 KCNH3 SLC6A1 HPN PKD1 ASIC4 TMEM109 SLC39A5 SLC4A11 | 1.36e-03 | 942 | 122 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.43e-03 | 82 | 122 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | polysaccharide catabolic process | 1.46e-03 | 38 | 122 | 3 | GO:0000272 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 1.49e-03 | 365 | 122 | 8 | GO:0006790 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 1.50e-03 | 208 | 122 | 6 | GO:0170033 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound biosynthetic process | 1.58e-03 | 39 | 122 | 3 | GO:0006779 | |
| GeneOntologyBiologicalProcess | tetrapyrrole biosynthetic process | 1.58e-03 | 39 | 122 | 3 | GO:0033014 | |
| GeneOntologyBiologicalProcess | gastrulation | 1.65e-03 | 212 | 122 | 6 | GO:0007369 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 1.69e-03 | 461 | 122 | 9 | GO:0006631 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.69e-03 | 461 | 122 | 9 | GO:0008544 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 1.70e-03 | 40 | 122 | 3 | GO:0072530 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 1.70e-03 | 40 | 122 | 3 | GO:1902110 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.70e-03 | 40 | 122 | 3 | GO:0015868 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.70e-03 | 86 | 122 | 4 | GO:0008652 | |
| GeneOntologyBiologicalProcess | learning or memory | 1.71e-03 | 373 | 122 | 8 | GO:0007611 | |
| GeneOntologyBiologicalProcess | keratinization | 1.78e-03 | 87 | 122 | 4 | GO:0031424 | |
| GeneOntologyBiologicalProcess | hexose mediated signaling | 1.84e-03 | 11 | 122 | 2 | GO:0009757 | |
| GeneOntologyBiologicalProcess | glucose mediated signaling pathway | 1.84e-03 | 11 | 122 | 2 | GO:0010255 | |
| GeneOntologyBiologicalProcess | regulation of CoA-transferase activity | 1.84e-03 | 11 | 122 | 2 | GO:1905918 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 1.03e-04 | 3 | 123 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | apical plasma membrane | CDHR5 SLC46A1 MFSD4B AQP5 ADCY8 SLC2A2 CHRNA7 HPN SLC2A13 CHRFAM7A SLC4A11 | 1.45e-04 | 487 | 123 | 11 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | CDHR5 SLC46A1 MFSD4B AQP5 ADCY8 SLC2A2 CHRNA7 HPN DCHS1 SLC2A13 CHRFAM7A SLC4A11 | 1.97e-04 | 592 | 123 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | microbody lumen | 3.09e-04 | 55 | 123 | 4 | GO:0031907 | |
| GeneOntologyCellularComponent | peroxisomal matrix | 3.09e-04 | 55 | 123 | 4 | GO:0005782 | |
| GeneOntologyCellularComponent | basal part of cell | SLC46A1 CLASP2 AQP5 ADCY8 SLC2A2 PKD1 SLC39A5 ABCC10 SLC4A11 | 4.04e-04 | 378 | 123 | 9 | GO:0045178 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 7.07e-04 | 7 | 123 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | axon | CLASP2 PLXND1 ADCY8 CHRNA7 TBC1D24 SLC6A1 NEFH HMCN2 PYGB SLC2A13 WDFY3 PUM1 CHRFAM7A CTSZ | 7.63e-04 | 891 | 123 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | cell projection membrane | CDHR5 SLC46A1 CLASP2 PLXND1 GPR88 SLC2A2 CHRNA7 PKD1 CHRFAM7A | 1.03e-03 | 431 | 123 | 9 | GO:0031253 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.19e-03 | 354 | 123 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | spine apparatus | 1.20e-03 | 9 | 123 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.44e-03 | 140 | 123 | 5 | GO:0016363 | |
| MousePheno | abnormal GABA-mediated receptor currents | 7.27e-06 | 18 | 101 | 4 | MP:0004008 | |
| MousePheno | complete atrioventricular septal defect | 3.40e-05 | 26 | 101 | 4 | MP:0010413 | |
| MousePheno | decreased cellular hemoglobin content | 4.23e-05 | 10 | 101 | 3 | MP:0008956 | |
| MousePheno | airway basal cell hyperplasia | 5.17e-05 | 2 | 101 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 5.17e-05 | 2 | 101 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 5.17e-05 | 2 | 101 | 2 | MP:0011113 | |
| MousePheno | abnormal coronary vessel morphology | 6.55e-05 | 59 | 101 | 5 | MP:0010551 | |
| MousePheno | impaired spatial working memory | 7.68e-05 | 12 | 101 | 3 | MP:0014370 | |
| MousePheno | abnormal cellular hemoglobin content | 7.68e-05 | 12 | 101 | 3 | MP:0008954 | |
| MousePheno | abnormal cornea endothelium morphology | 9.93e-05 | 13 | 101 | 3 | MP:0005301 | |
| MousePheno | failure of intramembranous bone ossification | 1.54e-04 | 3 | 101 | 2 | MP:0008276 | |
| MousePheno | abnormal fetal ductus arteriosus morphology | 2.76e-04 | 18 | 101 | 3 | MP:0010564 | |
| MousePheno | abnormal fear/anxiety-related behavior | SLC25A18 NRAP TENT4A NAGLU ACOT1 GPR88 NDRG3 ADCY8 CHRNA7 HHATL TENM4 TPH2 RIC8A SLC2A13 HSD17B4 CHRFAM7A MAF | 2.93e-04 | 919 | 101 | 17 | MP:0002065 |
| MousePheno | abnormal oligodendrocyte apoptosis | 3.07e-04 | 4 | 101 | 2 | MP:0010205 | |
| MousePheno | abnormal suprachiasmatic nucleus morphology | 3.07e-04 | 4 | 101 | 2 | MP:0008847 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 3.07e-04 | 4 | 101 | 2 | MP:0009475 | |
| Domain | PHOSPHORYLASE | 2.65e-07 | 3 | 121 | 3 | PS00102 | |
| Domain | Glycg_phsphrylas | 2.65e-07 | 3 | 121 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 2.65e-07 | 3 | 121 | 3 | IPR000811 | |
| Domain | Phosphorylase | 2.65e-07 | 3 | 121 | 3 | PF00343 | |
| Domain | Bile_Hydr_Trans | 1.06e-06 | 4 | 121 | 3 | PF04775 | |
| Domain | Thio_Ohase/aa_AcTrfase | 1.06e-06 | 4 | 121 | 3 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 1.06e-06 | 4 | 121 | 3 | IPR016662 | |
| Domain | BAAT_C | 2.63e-06 | 5 | 121 | 3 | IPR014940 | |
| Domain | Tmemb_14 | 2.63e-06 | 5 | 121 | 3 | PF03647 | |
| Domain | TMEM14 | 2.63e-06 | 5 | 121 | 3 | IPR005349 | |
| Domain | BAAT_C | 2.63e-06 | 5 | 121 | 3 | PF08840 | |
| Domain | Kelch_1 | 6.10e-06 | 70 | 121 | 6 | PF01344 | |
| Domain | Kelch_1 | 6.10e-06 | 70 | 121 | 6 | IPR006652 | |
| Domain | Keratin_2_head | 1.61e-05 | 24 | 121 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.61e-05 | 24 | 121 | 4 | PF16208 | |
| Domain | Keratin_II | 2.24e-05 | 26 | 121 | 4 | IPR003054 | |
| Domain | Kelch-typ_b-propeller | 2.82e-05 | 55 | 121 | 5 | IPR015915 | |
| Domain | Kelch | 3.66e-05 | 58 | 121 | 5 | SM00612 | |
| Domain | BACK | 4.31e-05 | 60 | 121 | 5 | SM00875 | |
| Domain | BACK | 4.68e-05 | 61 | 121 | 5 | IPR011705 | |
| Domain | BACK | 4.68e-05 | 61 | 121 | 5 | PF07707 | |
| Domain | Mit_carrier | 5.24e-05 | 32 | 121 | 4 | IPR002067 | |
| Domain | Intermediate_filament_CS | 5.47e-05 | 63 | 121 | 5 | IPR018039 | |
| Domain | Mit_uncoupling | 5.59e-05 | 12 | 121 | 3 | IPR002030 | |
| Domain | Filament | 9.72e-05 | 71 | 121 | 5 | SM01391 | |
| Domain | IF | 1.04e-04 | 72 | 121 | 5 | PS00226 | |
| Domain | Filament | 1.11e-04 | 73 | 121 | 5 | PF00038 | |
| Domain | PC_rep | 1.24e-04 | 3 | 121 | 2 | PF01851 | |
| Domain | Proteasome/cyclosome_rpt | 1.24e-04 | 3 | 121 | 2 | IPR002015 | |
| Domain | IF | 1.34e-04 | 76 | 121 | 5 | IPR001664 | |
| Domain | BTB-kelch_protein | 1.70e-04 | 43 | 121 | 4 | IPR017096 | |
| Domain | BTB | 2.11e-04 | 131 | 121 | 6 | PF00651 | |
| Domain | PSI | 2.22e-04 | 46 | 121 | 4 | SM00423 | |
| Domain | - | 2.62e-04 | 48 | 121 | 4 | 2.120.10.80 | |
| Domain | - | 3.84e-04 | 53 | 121 | 4 | 1.50.40.10 | |
| Domain | Mito_carr | 3.84e-04 | 53 | 121 | 4 | PF00153 | |
| Domain | SOLCAR | 3.84e-04 | 53 | 121 | 4 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.84e-04 | 53 | 121 | 4 | IPR018108 | |
| Domain | Mt_carrier_dom | 3.84e-04 | 53 | 121 | 4 | IPR023395 | |
| Domain | UbiB_dom | 4.11e-04 | 5 | 121 | 2 | IPR004147 | |
| Domain | ABC1 | 4.11e-04 | 5 | 121 | 2 | PF03109 | |
| Domain | Gal_Oxase/kelch_b-propeller | 5.79e-04 | 59 | 121 | 4 | IPR011043 | |
| Domain | BTB | 6.15e-04 | 160 | 121 | 6 | PS50097 | |
| Domain | - | 6.93e-04 | 27 | 121 | 3 | 2.130.10.80 | |
| Domain | Aden_trnslctor | 7.72e-04 | 28 | 121 | 3 | IPR002113 | |
| Domain | - | 1.07e-03 | 119 | 121 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.07e-03 | 119 | 121 | 5 | IPR029058 | |
| Domain | BTB | 1.13e-03 | 180 | 121 | 6 | SM00225 | |
| Domain | Sugar_transporter_CS | 1.15e-03 | 32 | 121 | 3 | IPR005829 | |
| Domain | Plexin_repeat | 1.15e-03 | 32 | 121 | 3 | IPR002165 | |
| Domain | PSI | 1.15e-03 | 32 | 121 | 3 | PF01437 | |
| Domain | BTB/POZ_dom | 1.31e-03 | 185 | 121 | 6 | IPR000210 | |
| Domain | Gal_Oxidase_b-propeller | 1.37e-03 | 34 | 121 | 3 | IPR015916 | |
| Domain | SKP1/BTB/POZ | 1.46e-03 | 189 | 121 | 6 | IPR011333 | |
| Domain | MFS_dom | 1.80e-03 | 134 | 121 | 5 | IPR020846 | |
| Domain | GrpE_coiled_coil | 2.63e-03 | 12 | 121 | 2 | IPR013805 | |
| Domain | PSI | 2.89e-03 | 44 | 121 | 3 | IPR016201 | |
| Domain | Sugar/inositol_transpt | 3.60e-03 | 14 | 121 | 2 | IPR003663 | |
| Domain | ADH_SHORT | 4.91e-03 | 53 | 121 | 3 | PS00061 | |
| Domain | SUGAR_TRANSPORT_2 | 5.31e-03 | 17 | 121 | 2 | PS00217 | |
| Domain | adh_short | 5.45e-03 | 55 | 121 | 3 | PF00106 | |
| Domain | SDR_fam | 5.73e-03 | 56 | 121 | 3 | IPR002347 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC25A18 SLC25A4 SLC25A5 SLC25A6 PSMD2 ABCC9 SLC46A1 MFSD4B AQP5 ADCY8 SLC2A2 SLC6A1 CLN3 SLC2A13 ASIC4 SLC39A5 ABCC10 | 2.92e-06 | 736 | 89 | 17 | M27287 |
| Pathway | KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS | 9.95e-06 | 22 | 89 | 4 | M11673 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 1.99e-05 | 9 | 89 | 3 | M47621 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC25A18 SLC25A4 SLC25A5 SLC25A6 MFSD4B SLC2A2 SLC6A1 SLC2A13 SLC39A5 | 2.69e-05 | 249 | 89 | 9 | M5988 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 2.83e-05 | 10 | 89 | 3 | M47694 | |
| Pathway | REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 3.87e-05 | 11 | 89 | 3 | M27298 | |
| Pathway | REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS | 3.87e-05 | 11 | 89 | 3 | MM15002 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 5.14e-05 | 12 | 89 | 3 | M27728 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 5.49e-05 | 65 | 89 | 5 | MM15628 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.65e-05 | 13 | 89 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 6.65e-05 | 13 | 89 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.65e-05 | 13 | 89 | 3 | M47703 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 8.42e-05 | 14 | 89 | 3 | M19193 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 8.42e-05 | 14 | 89 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.05e-04 | 15 | 89 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.85e-04 | 18 | 89 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.85e-04 | 18 | 89 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 2.19e-04 | 19 | 89 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.19e-04 | 19 | 89 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.57e-04 | 20 | 89 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.98e-04 | 21 | 89 | 3 | M47689 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC25A18 SLC25A4 SLC25A5 PSMD2 ABCC9 SLC46A1 AQP5 SLC2A2 SLC6A1 CLN3 SLC2A13 ASIC4 ABCC10 | 3.29e-04 | 681 | 89 | 13 | MM14985 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.43e-04 | 22 | 89 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.43e-04 | 22 | 89 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA | 3.89e-04 | 5 | 89 | 2 | M49001 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.93e-04 | 23 | 89 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.93e-04 | 23 | 89 | 3 | M47676 | |
| Pathway | REACTOME_PROTEIN_LOCALIZATION | 4.82e-04 | 103 | 89 | 5 | MM15653 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 5.06e-04 | 25 | 89 | 3 | M27857 | |
| Pathway | REACTOME_PROTEIN_LOCALIZATION | 5.93e-04 | 164 | 89 | 6 | M27932 | |
| Pathway | WP_7OXOC_AND_7BETAHC_PATHWAYS | 6.38e-04 | 27 | 89 | 3 | M40054 | |
| Pathway | REACTOME_PEROXISOMAL_PROTEIN_IMPORT | 6.66e-04 | 63 | 89 | 4 | M27915 | |
| Pathway | REACTOME_PEROXISOMAL_LIPID_METABOLISM | 7.11e-04 | 28 | 89 | 3 | MM15010 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.16e-04 | 170 | 89 | 6 | MM15573 | |
| Pathway | REACTOME_PEROXISOMAL_LIPID_METABOLISM | 7.89e-04 | 29 | 89 | 3 | M2286 | |
| Pathway | REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS | 8.11e-04 | 7 | 89 | 2 | M27916 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 8.58e-04 | 176 | 89 | 6 | M27854 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.26e-03 | 34 | 89 | 3 | MM15985 | |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 1.38e-03 | 9 | 89 | 2 | M3061 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.62e-03 | 37 | 89 | 3 | M1029 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 1.72e-03 | 10 | 89 | 2 | M15371 | |
| Pathway | REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION | 1.78e-03 | 82 | 89 | 4 | MM17230 | |
| Pathway | WP_NRF2_PATHWAY | 1.97e-03 | 141 | 89 | 5 | M39454 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.03e-03 | 40 | 89 | 3 | M39595 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 2.09e-03 | 11 | 89 | 2 | MM15471 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SDSL FLNC SPEG NAGLU CLASP2 PLXND1 ARHGEF10L KCNH3 TBC1D24 GGT7 MEGF8 CLN3 PKD1 PIGW PYGB RIC8A WDFY3 PUM1 CTSZ ABCC10 | 2.82e-09 | 1105 | 125 | 20 | 35748872 |
| Pubmed | Identification of the Mitochondrial Heme Metabolism Complex. | 1.08e-08 | 21 | 125 | 5 | 26287972 | |
| Pubmed | PTGES2 SLC25A4 SLC25A5 ETFDH ACOT1 PRDX3 LYPLA1 PYGB PYGM ACOT2 UQCRC2 | 3.47e-08 | 331 | 125 | 11 | 29199018 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | SDSL KRT5 PTGES2 ACAA1 SLC25A4 SLC25A5 ADCK5 ETFDH TMEM14C ADCK2 ACOT1 TMEM14DP PRDX3 TMEM14B ACOT2 UQCRC2 HSD17B4 QDPR | 4.13e-08 | 1047 | 125 | 18 | 18614015 |
| Pubmed | TMEM14C is required for erythroid mitochondrial heme metabolism. | 4.53e-08 | 3 | 125 | 3 | 25157825 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 4.53e-08 | 3 | 125 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 4.53e-08 | 3 | 125 | 3 | 2829183 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 10567408 | ||
| Pubmed | PTGES2 ACAA1 SLC25A4 SLC25A5 COPB2 ETFDH TMEM14C ACOT1 MOGS PRDX3 LYPLA1 PGLS UQCRC2 HSD17B4 PYCR2 TMEM109 | 8.48e-08 | 859 | 125 | 16 | 31536960 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 15007068 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 33396658 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 16940157 | ||
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | PTGES2 ACAA1 SLC25A4 SLC25A5 ETFDH ACOT1 PRDX3 ACOT2 UQCRC2 HSD17B4 | 4.97e-07 | 343 | 125 | 10 | 28130547 |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 10620603 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | SDSL KRT5 PTGES2 SLC25A18 ACAA1 SLC25A4 ADCK5 ETFDH TMEM14C ADCK2 PRDX3 ACOT2 UQCRC2 HSD17B4 QDPR | 1.28e-06 | 926 | 125 | 15 | 20877624 |
| Pubmed | Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis. | 1.57e-06 | 7 | 125 | 3 | 19656490 | |
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 21370995 | ||
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 2.18e-06 | 58 | 125 | 5 | 37117185 | |
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 27641616 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | PTGES2 SLC25A18 SLC25A4 SLC25A5 SLC25A6 ADCK5 ETFDH TMEM14C ADCK2 ACOT1 PRDX3 LYPLA1 ACOT2 UQCRC2 PYCR2 QDPR | 3.35e-06 | 1136 | 125 | 16 | 34800366 |
| Pubmed | A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. | 3.75e-06 | 9 | 125 | 3 | 16103133 | |
| Pubmed | SLC25A5 ETFDH TMEM14C ACOT1 TMEM14DP NEFH CLN3 PRDX3 TMEM14B LYPLA1 ACOT2 | 4.46e-06 | 542 | 125 | 11 | 14651853 | |
| Pubmed | 6.83e-06 | 73 | 125 | 5 | 23464991 | ||
| Pubmed | KRT5 SLC25A4 SLC25A5 SLC25A6 DBNL PSMD2 KRT77 SMARCA4 PYGB UQCRC2 PYCR2 TMEM109 CTSZ | 6.86e-06 | 803 | 125 | 13 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNC UAP1 ACAA1 SLC25A5 SLC25A6 COPB2 TMEM14C PSMD2 MOGS KRT77 PRDX3 PGLS PYGB | 7.23e-06 | 807 | 125 | 13 | 30575818 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | SLC25A18 SLC25A5 DBNL COPB2 PSMD2 KEAP1 TBC1D24 MOGS ANAPC1 PYGL UQCRC2 | 7.29e-06 | 571 | 125 | 11 | 37167062 |
| Pubmed | MRI1 SLC25A4 SLC25A5 SLC25A6 PSMD2 ACOT1 MFSD4B SEMA4C ICMT PYGL ACOT2 UQCRC2 HSD17B4 PYCR2 | 8.86e-06 | 952 | 125 | 14 | 38569033 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRI1 SLC25A4 SLC25A5 SLC25A6 COPB2 KEAP1 LYPLA1 PGLS SMARCA4 RIC8A UQCRC2 PYCR2 | 9.46e-06 | 704 | 125 | 12 | 29955894 |
| Pubmed | 9.74e-06 | 12 | 125 | 3 | 16120388 | ||
| Pubmed | PTGES2 SLC25A4 SLC25A5 ETFDH ACOT1 PRDX3 ACOT2 UQCRC2 HSD17B4 | 1.06e-05 | 382 | 125 | 9 | 29222160 | |
| Pubmed | SLC25A5 MOGS PRDX3 SMARCA4 UHRF1 PYGL RIC8A UQCRC2 PYCR2 LSM14B PUM1 | 1.17e-05 | 601 | 125 | 11 | 33658012 | |
| Pubmed | 1.21e-05 | 82 | 125 | 5 | 20833797 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38070724 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34453977 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26999808 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27129924 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 1.28e-05 | 2 | 125 | 2 | 23521765 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 28258105 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19344760 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29114104 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 33995108 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32552811 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24836856 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15948184 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35678315 | ||
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 1.28e-05 | 2 | 125 | 2 | 12628457 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 25157794 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 1.28e-05 | 2 | 125 | 2 | 22246862 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 27471776 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22688057 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32028688 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 1.28e-05 | 2 | 125 | 2 | 21501254 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21368056 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 1400473 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26937017 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 36603528 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 1.28e-05 | 2 | 125 | 2 | 26650489 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22848433 | ||
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 1.28e-05 | 2 | 125 | 2 | 16650968 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35413868 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24462939 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 1.28e-05 | 2 | 125 | 2 | 18199426 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22490926 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23270857 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 18077004 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19462340 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 16923147 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11790782 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 37746145 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19631623 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15770102 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 24326163 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26842067 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 23811428 | ||
| Pubmed | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. | 1.28e-05 | 2 | 125 | 2 | 20720594 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 17019565 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 19100751 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.28e-05 | 2 | 125 | 2 | 14749836 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 35883638 | ||
| Pubmed | Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels. | 1.28e-05 | 2 | 125 | 2 | 19368846 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 15009674 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38253622 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 34514543 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 22183893 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 9364063 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 12606407 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 11330065 | ||
| Pubmed | Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. | 1.28e-05 | 2 | 125 | 2 | 22300029 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 32018068 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 26206074 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 1.28e-05 | 2 | 125 | 2 | 24349346 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 21143250 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 1.28e-05 | 2 | 125 | 2 | 16319313 | |
| Pubmed | Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. | 1.28e-05 | 2 | 125 | 2 | 25797465 | |
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 29197398 | ||
| Pubmed | 1.28e-05 | 2 | 125 | 2 | 38178134 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.24e-05 | 423 | 125 | 8 | chr12q13 | |
| Cytoband | 12q13.13 | 3.52e-05 | 67 | 125 | 4 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 1.56e-04 | 184 | 125 | 5 | chr3p22 | |
| Cytoband | 12q21.1 | 8.61e-04 | 16 | 125 | 2 | 12q21.1 | |
| Cytoband | 3p22.2 | 1.95e-03 | 24 | 125 | 2 | 3p22.2 | |
| Cytoband | 14q24.3 | 2.14e-03 | 93 | 125 | 3 | 14q24.3 | |
| Cytoband | 3p22.3 | 3.25e-03 | 31 | 125 | 2 | 3p22.3 | |
| Cytoband | 19p13.2 | 3.65e-03 | 229 | 125 | 4 | 19p13.2 | |
| Cytoband | 11p15.5 | 4.19e-03 | 118 | 125 | 3 | 11p15.5 | |
| GeneFamily | Glycogen phosphorylases | 8.99e-08 | 3 | 82 | 3 | 437 | |
| GeneFamily | Solute carriers | SLC25A18 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC35G6 SLC2A2 SLC6A1 SLC2A13 SLC39A5 SLC4A11 | 1.64e-06 | 395 | 82 | 11 | 752 |
| GeneFamily | Keratins, type II | 6.37e-06 | 27 | 82 | 4 | 609 | |
| GeneFamily | Acyl-CoA thioesterases | 1.05e-05 | 10 | 82 | 3 | 41 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.27e-05 | 134 | 82 | 6 | 861 | |
| GeneFamily | Kelch like|BTB domain containing | 3.86e-05 | 42 | 82 | 4 | 617 | |
| GeneFamily | ATP binding cassette subfamily C | 1.53e-03 | 13 | 82 | 2 | 807 | |
| GeneFamily | Cadherin related | 2.64e-03 | 17 | 82 | 2 | 24 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 4.98e-03 | 76 | 82 | 3 | 743 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 4.43e-07 | 143 | 125 | 8 | MM989 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 2.13e-06 | 123 | 125 | 7 | M13788 | |
| Coexpression | NADERI_BREAST_CANCER_PROGNOSIS_UP | 4.49e-06 | 51 | 125 | 5 | M6862 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_LGI2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-08 | 179 | 124 | 8 | 8dd10e3a9ab39d9a770cecac6e2ed3676b79e906 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.21e-07 | 159 | 124 | 7 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.69e-07 | 181 | 124 | 7 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-07 | 183 | 124 | 7 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-07 | 183 | 124 | 7 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1-CHRNA6-L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | c210c34c9a4d9630d58e62a5e790c68411ab1008 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1-CHRNA6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 3723e0898dfc846f33d71b319941d65f466b98d7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 9f21e4e0913d8ef95a3f771dff0abaad8fe1d9f2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-06 | 149 | 124 | 6 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.23e-06 | 170 | 124 | 6 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.51e-06 | 171 | 124 | 6 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-06 | 172 | 124 | 6 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.80e-06 | 172 | 124 | 6 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 177 | 124 | 6 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 177 | 124 | 6 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 179 | 124 | 6 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.14e-05 | 180 | 124 | 6 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-05 | 181 | 124 | 6 | 42f5a645beeb5a1a746d79ea7fe7fd3786fd35ad | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-1|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.18e-05 | 181 | 124 | 6 | 78b646feca39d1bfd68f9843b7f557b3fac56829 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 182 | 124 | 6 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 124 | 6 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 182 | 124 | 6 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 183 | 124 | 6 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 183 | 124 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-05 | 185 | 124 | 6 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-05 | 187 | 124 | 6 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-05 | 187 | 124 | 6 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 191 | 124 | 6 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-05 | 192 | 124 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 194 | 124 | 6 | fb234d97191c95b7880280c6e4ed5df124ffb0e1 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-05 | 195 | 124 | 6 | 0fcc41cda3e5f921748cf7e7fe48dd7ca1de4636 | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-05 | 197 | 124 | 6 | 17c6d2a7baef6393c3e2d3e65cc924df22049eb0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-05 | 197 | 124 | 6 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | normal-na-Myeloid-conventional_dendritic_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.90e-05 | 197 | 124 | 6 | 9a0bcb055b1a5fd5439e4a0bf1742f009331df47 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 197 | 124 | 6 | 9b038dac4d4d306aa40ec07d79374c4fe9c604a6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | a9d72b17adfddb6ac1857c5f094280e86582693b | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | b933bd66f544822fcf1f2aa2d928c31500e2b3f4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | 72733b6149b797ac11cc108bc80428b77fbbba78 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 198 | 124 | 6 | 8fbc461315986e357a0961a261ed10880637d6ad | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | f23559ce6072e3c323f6791ff95269271b0f7ff1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 199 | 124 | 6 | 4bde35e5df019189433d65d415e29a0c1145ac66 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 199 | 124 | 6 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 523d799eb315b33b77e02d5b7db63dad8450c4e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | e5cef95e563a6e793ade190ce88c999bfa0af460 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1-CASC6-L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 8576906df19ea1383e2221709b3b309b1bbba28d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_1-CASC6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 1d397ad55f0f7a7dd72aa5a3331d2e0db07f0d39 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.07e-05 | 200 | 124 | 6 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-05 | 200 | 124 | 6 | af743dfef7e7cfaef1c494999757123f93a213e3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-05 | 127 | 124 | 5 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-05 | 128 | 124 | 5 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.96e-05 | 128 | 124 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.39e-05 | 139 | 124 | 5 | 408bc31aa5e1c2b379f79198fe8b5411f8d7bd08 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.55e-05 | 146 | 124 | 5 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.55e-05 | 146 | 124 | 5 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.92e-05 | 148 | 124 | 5 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.71e-05 | 152 | 124 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.36e-05 | 155 | 124 | 5 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.36e-05 | 155 | 124 | 5 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.36e-05 | 155 | 124 | 5 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.59e-05 | 156 | 124 | 5 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.55e-05 | 160 | 124 | 5 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.81e-05 | 161 | 124 | 5 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.81e-05 | 161 | 124 | 5 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.33e-05 | 163 | 124 | 5 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.89e-05 | 165 | 124 | 5 | c6b23013d77fa9aa967b76e451c8e42b0a657c30 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 166 | 124 | 5 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 88 | 124 | 4 | 2075743c7c0b6d74e80464a6bc776206d744d502 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 88 | 124 | 4 | a49319bc97188550e08248973e10c626124c3917 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.07e-04 | 88 | 124 | 4 | 14b11249a2b3fa327622897fe74630c2697ea47e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 168 | 124 | 5 | f3879a8e11eaf866f37c52e67021be43f0b8784a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-04 | 170 | 124 | 5 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 91 | 124 | 4 | f59908093416ca7b3ca27019d71c79acbdea18cb | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 91 | 124 | 4 | 104d2ab9fe5cc404388c32fafb34e421c2e138be | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 91 | 124 | 4 | 78e2e65beb15bf1e251974c72fbcfab817492772 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 174 | 124 | 5 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-04 | 175 | 124 | 5 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 176 | 124 | 5 | 23f930dac5247ea6d4124da33933d61ad6e089af | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-04 | 176 | 124 | 5 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 177 | 124 | 5 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.37e-04 | 177 | 124 | 5 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 178 | 124 | 5 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| Drug | carnitine | ACAA1 SLC25A4 SLC25A5 SLC25A6 ETFDH ACOT4 CLN3 PYGB PYGL PYGM ACOT2 UQCRC2 | 2.65e-08 | 265 | 125 | 12 | CID000000085 |
| Drug | 6-methylpurine | 5.96e-08 | 8 | 125 | 4 | CID005287547 | |
| Drug | 3,5-dimethylphenyl isocyanate | 1.62e-07 | 3 | 125 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 1.62e-07 | 3 | 125 | 3 | CID000147839 | |
| Drug | NSC758405 | 1.62e-07 | 3 | 125 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 1.62e-07 | 3 | 125 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 1.62e-07 | 3 | 125 | 3 | CID000196007 | |
| Drug | Clodronate | 1.62e-07 | 3 | 125 | 3 | DB00720 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 1.62e-07 | 3 | 125 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 1.62e-07 | 3 | 125 | 3 | CID000191554 | |
| Drug | hydan | 1.62e-07 | 3 | 125 | 3 | CID000008360 | |
| Drug | EHMF | 1.62e-07 | 3 | 125 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 1.62e-07 | 3 | 125 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 1.62e-07 | 3 | 125 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 1.62e-07 | 3 | 125 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 1.62e-07 | 3 | 125 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 1.62e-07 | 3 | 125 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 1.62e-07 | 3 | 125 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 1.62e-07 | 3 | 125 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 1.62e-07 | 3 | 125 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 1.62e-07 | 3 | 125 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 1.62e-07 | 3 | 125 | 3 | CID000011459 | |
| Drug | Cid 11299980 | 2.77e-07 | 11 | 125 | 4 | CID009856533 | |
| Drug | n-propionyl-CoA | SDSL ACAA1 SLC25A4 SLC25A5 SLC25A6 ETFDH ACOT4 ACOT2 HSD17B4 | 3.48e-07 | 166 | 125 | 9 | CID000001033 |
| Drug | galocitabine | 6.44e-07 | 4 | 125 | 3 | CID000065950 | |
| Drug | dehydroabietylamine | 6.44e-07 | 4 | 125 | 3 | ctd:C000600819 | |
| Drug | 5-deoxyribose-1-phosphate | 6.44e-07 | 4 | 125 | 3 | CID000135786 | |
| Drug | ingliforib | 6.44e-07 | 4 | 125 | 3 | CID006451325 | |
| Drug | uric acid riboside | 6.44e-07 | 4 | 125 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 6.44e-07 | 4 | 125 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 6.44e-07 | 4 | 125 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 6.44e-07 | 4 | 125 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 6.44e-07 | 4 | 125 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 6.44e-07 | 4 | 125 | 3 | CID000094262 | |
| Drug | Mem-CC | 6.44e-07 | 4 | 125 | 3 | CID003081269 | |
| Drug | BCIp4A | 6.44e-07 | 4 | 125 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 6.44e-07 | 4 | 125 | 3 | CID000097703 | |
| Drug | NSC 204984 | 8.31e-07 | 14 | 125 | 4 | CID000307185 | |
| Drug | 5-methylthioribose-1-phosphate | 1.50e-06 | 16 | 125 | 4 | CID000000465 | |
| Drug | heptulose-2-P | 1.60e-06 | 5 | 125 | 3 | CID000124823 | |
| Drug | 6-FPLP | 1.60e-06 | 5 | 125 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 1.60e-06 | 5 | 125 | 3 | CID009576855 | |
| Drug | DHPBU | 1.60e-06 | 5 | 125 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 1.60e-06 | 5 | 125 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 1.60e-06 | 5 | 125 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 1.60e-06 | 5 | 125 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 1.60e-06 | 5 | 125 | 3 | CID000080578 | |
| Drug | etafenone | 1.60e-06 | 5 | 125 | 3 | CID000003275 | |
| Drug | ddEtUrd | 1.60e-06 | 5 | 125 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 1.60e-06 | 5 | 125 | 3 | CID000125618 | |
| Drug | m-anisidine | 1.60e-06 | 5 | 125 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 1.60e-06 | 5 | 125 | 3 | CID000441028 | |
| Drug | 6-FDPL | 1.60e-06 | 5 | 125 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 1.60e-06 | 5 | 125 | 3 | CID003082179 | |
| Drug | GlcMan | 1.60e-06 | 5 | 125 | 3 | CID000152120 | |
| Drug | U66985 | 1.60e-06 | 5 | 125 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 1.60e-06 | 5 | 125 | 3 | CID006331955 | |
| Drug | homonojirimycin | 1.95e-06 | 17 | 125 | 4 | CID000159496 | |
| Drug | beta-hydroxypalmitoyl-CoA | 1.95e-06 | 17 | 125 | 4 | CID000440600 | |
| Drug | fagomine | 1.95e-06 | 17 | 125 | 4 | CID000072259 | |
| Drug | 1-GlcNAc | 2.50e-06 | 18 | 125 | 4 | CID000151446 | |
| Drug | ADP alpha S | 3.15e-06 | 19 | 125 | 4 | CID000171069 | |
| Drug | CV-araU | 3.19e-06 | 6 | 125 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 3.19e-06 | 6 | 125 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 3.19e-06 | 6 | 125 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 3.19e-06 | 6 | 125 | 3 | CID000152984 | |
| Drug | EdUMP | 3.19e-06 | 6 | 125 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 3.19e-06 | 6 | 125 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 3.19e-06 | 6 | 125 | 3 | CID000656428 | |
| Drug | AzddCyd | 3.19e-06 | 6 | 125 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 3.19e-06 | 6 | 125 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 3.19e-06 | 6 | 125 | 3 | CID006439191 | |
| Drug | DNPP | 3.19e-06 | 6 | 125 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 3.19e-06 | 6 | 125 | 3 | CID000082693 | |
| Drug | NSC-97433 | 3.19e-06 | 6 | 125 | 3 | CID000001803 | |
| Drug | AR-L57 | 3.19e-06 | 6 | 125 | 3 | CID000156890 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 5.56e-06 | 7 | 125 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 5.56e-06 | 7 | 125 | 3 | CID003080803 | |
| Drug | AC1L3372 | 5.56e-06 | 7 | 125 | 3 | CID000108025 | |
| Drug | 1 Gpt | 5.56e-06 | 7 | 125 | 3 | CID000101247 | |
| Drug | formycins | 5.56e-06 | 7 | 125 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 5.56e-06 | 7 | 125 | 3 | CID000161214 | |
| Drug | hydantocidin | 5.56e-06 | 7 | 125 | 3 | CID000125429 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 5.56e-06 | 7 | 125 | 3 | CID000356019 | |
| Drug | heptenitol | 5.56e-06 | 7 | 125 | 3 | CID000188267 | |
| Drug | Promonta | 5.56e-06 | 7 | 125 | 3 | CID000108494 | |
| Drug | closantel | 5.56e-06 | 7 | 125 | 3 | ctd:C023342 | |
| Drug | ginsenoside | 7.07e-06 | 23 | 125 | 4 | CID000092797 | |
| Drug | Etafenone [inn] | 8.87e-06 | 8 | 125 | 3 | CID000066659 | |
| Drug | AC1NUVX5 | 8.87e-06 | 8 | 125 | 3 | CID005461894 | |
| Drug | amorphin | 8.87e-06 | 8 | 125 | 3 | CID000122792 | |
| Drug | N-nitrosomorpholine | 9.73e-06 | 52 | 125 | 5 | CID000006046 | |
| Drug | hexylamine | 1.00e-05 | 25 | 125 | 4 | CID000008102 | |
| Drug | propofol | 1.08e-05 | 191 | 125 | 8 | CID000004943 | |
| Drug | alpha-maltosyl fluoride | 1.32e-05 | 9 | 125 | 3 | CID000194237 | |
| Drug | 6-benzyl-2-thiouracil | 1.32e-05 | 9 | 125 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 1.32e-05 | 9 | 125 | 3 | CID000188350 | |
| Drug | 5-Iodoribose 1-phosphate | 1.32e-05 | 9 | 125 | 3 | CID003035973 | |
| Drug | Ponceau S solution | 1.32e-05 | 9 | 125 | 3 | CID005473620 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 1.32e-05 | 9 | 125 | 3 | CID000107502 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 2.82e-07 | 4 | 123 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 6.30e-06 | 29 | 123 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | myoclonic-atonic epilepsy (is_implicated_in) | 1.72e-05 | 2 | 123 | 2 | DOID:0060475 (is_implicated_in) | |
| Disease | dodecadienoate (12:2) measurement | 1.71e-04 | 5 | 123 | 2 | EFO_0800572 | |
| Disease | cognitive disorder (implicated_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 2.56e-04 | 6 | 123 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | X-16935 measurement | 3.57e-04 | 7 | 123 | 2 | EFO_0800763 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 4.20e-04 | 35 | 123 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | X-24747 measurement | 4.75e-04 | 8 | 123 | 2 | EFO_0022135 | |
| Disease | glycogen storage disease (is_implicated_in) | 6.09e-04 | 9 | 123 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | X-17653 measurement | 6.09e-04 | 9 | 123 | 2 | EFO_0800783 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.04e-03 | 274 | 123 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.08e-03 | 276 | 123 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.11e-03 | 12 | 123 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | decanoylcarnitine measurement | 1.11e-03 | 12 | 123 | 2 | EFO_0021039 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.27e-03 | 51 | 123 | 3 | EFO_0022285 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.30e-03 | 13 | 123 | 2 | C0369183 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 1.30e-03 | 13 | 123 | 2 | EFO_0800588 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.30e-03 | 13 | 123 | 2 | C1261502 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.52e-03 | 14 | 123 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | X-17654 measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0800784 | |
| Disease | Withdrawal Symptoms | 1.85e-03 | 58 | 123 | 3 | C0087169 | |
| Disease | low density lipoprotein particle size measurement | 1.85e-03 | 58 | 123 | 3 | EFO_0008593 | |
| Disease | Drug Withdrawal Symptoms | 1.85e-03 | 58 | 123 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.85e-03 | 58 | 123 | 3 | C0038587 | |
| Disease | Tetralogy of Fallot | 1.99e-03 | 16 | 123 | 2 | C0039685 | |
| Disease | obesity (implicated_via_orthology) | 2.11e-03 | 215 | 123 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 2.91e-03 | 68 | 123 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy | 3.12e-03 | 20 | 123 | 2 | EFO_0000407 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.77e-03 | 22 | 123 | 2 | C3711387 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 3.77e-03 | 22 | 123 | 2 | C1843687 | |
| Disease | Bipolar Disorder | 3.93e-03 | 477 | 123 | 7 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSLQGLEYGGQRGDA | 26 | Q8N2C9 | |
| TGGGLLEYRASLLAG | 166 | Q86TX2 | |
| QILAAGLGYGLLGDG | 256 | P40145 | |
| RYFAGNLASGGAAGA | 111 | P12236 | |
| AVGGLRELFGYLGNG | 246 | Q7Z695 | |
| ISGGQGYRNFGSALG | 1241 | Q9HCE6 | |
| LGTGDLGCYGNNTLR | 51 | P51689 | |
| LRDGALVFSYNLGSG | 896 | Q63HQ2 | |
| LLAGAAQGGLYFRRG | 16 | Q9UBR2 | |
| GARARFALGLSGGSL | 36 | O95336 | |
| YGGLLLLATASGNAN | 696 | P35606 | |
| LRLEGGGLIAGNNIY | 491 | Q9UK96 | |
| LYFAGNLASGGAAGA | 111 | P05141 | |
| FGTGGGLLEYRASLL | 226 | P49753 | |
| GSSNSGLVGLGLLYA | 1241 | O60706 | |
| ADALVAGAISNGGLY | 131 | Q3MIX3 | |
| GRYSGNAGDAFRGLK | 276 | Q86XS5 | |
| QRLYRGTVARGAGAG | 356 | Q9HBB8 | |
| YGGRGALGSRCVQAF | 16 | P09417 | |
| NGNLLYIGFRGLDGV | 381 | P36544 | |
| GAGILYGVAPLNARG | 101 | P55064 | |
| GLDTYSLGGGGAARV | 61 | P54802 | |
| LCAAAGYALGAGTRL | 6 | C0HLV8 | |
| RGGLGLSGAKANYRG | 241 | P22695 | |
| LNGGYRGNEGTLESI | 346 | O60870 | |
| LRGELSYNLGAGGGS | 696 | Q9ULD8 | |
| ALGLLFLGGGRYSLS | 1561 | Q9H1A4 | |
| SHGLLYALGLAGGAV | 321 | Q5T3U5 | |
| GVGAGAYILSRFALN | 136 | Q9UGV2 | |
| DAGRLGTQGYALSGD | 171 | Q96JQ0 | |
| FSADLGYNGTRQRGG | 51 | Q96NT5 | |
| GEGGASSLRDLYVLG | 486 | Q8N239 | |
| GGGLAALDAAAGEYS | 326 | Q9H2Z4 | |
| LLYSGLAIGGTLANG | 36 | Q9GZN0 | |
| DGAGGSYRLLRGGLL | 106 | Q9GZN0 | |
| GALAYAGRGLLEASQ | 21 | Q9HCP6 | |
| GGFDGYARGAQQLAA | 126 | O75444 | |
| YARGAQQLAAAAGAG | 131 | O75444 | |
| GGSGLLQGSRARSYG | 11 | Q96S90 | |
| GLGLYGDFGSAAAGL | 196 | Q99684 | |
| GGRHAAAAAALQLYG | 41 | P13378 | |
| ARAGQGAAVSYLLGR | 151 | O95872 | |
| NARGLGLQGAYRGAE | 1686 | Q86VF7 | |
| KAGAQLGARGSGYRV | 3886 | Q8NDA2 | |
| LLSQQYAASLGLGAG | 131 | Q9BX40 | |
| RSGAGGFGSRSLYNL | 46 | P12035 | |
| LAGACGVGGYGSRSL | 51 | P13647 | |
| LGLQCAGGAGRGDLY | 341 | Q9Y4D7 | |
| GTYLALGANGAARGL | 556 | Q9UJ14 | |
| TRNAGYGGLGLSIEG | 2066 | Q14315 | |
| AGRSISGLYCGLISG | 156 | P11168 | |
| LGGSVLLVAGGYSGR | 521 | Q7Z7M0 | |
| SRLYISGGFGGVALG | 1851 | Q7Z7M0 | |
| LAGLLGGAGAQYSSD | 36 | Q641Q3 | |
| RAAYGLSALLGDLGG | 431 | Q96FT7 | |
| NGNLLYIGFRGLDGV | 291 | Q494W8 | |
| RYDGAHLCGGSLLSG | 181 | P05981 | |
| GLLRSASLASLYNGG | 196 | Q9Y608 | |
| RALGYLSGSVIGGFL | 41 | Q5TF39 | |
| YLLSGSRAAALSGGG | 181 | Q5XG87 | |
| GQAALSGLLGGIGYF | 391 | Q13724 | |
| SLNLGGLTNGSGRYI | 771 | Q14671 | |
| YALARKGGAGGTRSA | 26 | P12036 | |
| SSVLGLSYLQGGGAG | 46 | P43694 | |
| AGLAGREQYGRAGFA | 141 | P43694 | |
| GKRIAYGARALNEGG | 356 | Q16134 | |
| GGALLGVLQYRGAEL | 146 | O75173 | |
| AGLQGRTGLALYVAG | 36 | O60725 | |
| IAGLIYAVGGLNSAG | 286 | O94889 | |
| DGGGLLYGLASGVAT | 241 | Q7RTS9 | |
| LAGYGCVLGASSGNL | 16 | Q86YW7 | |
| SGTLYKNRLGSGGRG | 211 | O75398 | |
| SLYAAGERGGHLQGA | 401 | Q12948 | |
| TQGLAGLYRGLGATL | 176 | Q9H1K4 | |
| GAGAGLGRAYALAFA | 16 | P51659 | |
| GGFSQGGALSLYTAL | 116 | O75608 | |
| GAAVAQDLLALGYGG | 11 | Q17RN3 | |
| GGLLYAVGGRNNSPD | 371 | Q14145 | |
| LATLILGGGGYNLAN | 296 | Q9BY41 | |
| YGSQARLGVRGGLVL | 526 | Q5FWE3 | |
| GQGLSGQGLCARALY | 366 | Q9UJU6 | |
| GGSGLEAAYSIVALG | 381 | P98161 | |
| GKYLRGGASGLLRAD | 466 | O14926 | |
| LAGGALNGVFGRRAA | 136 | Q96QE2 | |
| AGQSIGGLLYALFSG | 396 | Q8NBS3 | |
| ASIAGGIRNGSYDIG | 131 | P09110 | |
| YGLGLGSLIALGSYN | 296 | P30531 | |
| LDYGDNGFGAGRGQL | 1881 | O14513 | |
| SIFGLGLAYAGSNRE | 481 | Q13200 | |
| AAGANLNGIIYLLGG | 371 | Q9NVX7 | |
| TGGIVQGLDLYRASG | 1066 | P51532 | |
| GALATAGYGTALGVI | 171 | Q9BV20 | |
| DYGVLLEGSGLALRG | 171 | P30048 | |
| IGAGQLAYALARGFT | 6 | Q96C36 | |
| AAALALGGALGLYHT | 61 | Q9H7Z7 | |
| ANGYVRLQLGGEDRG | 786 | Q9C0C4 | |
| ITSVLGRLAANGGGY | 161 | Q92781 | |
| TGYGNAAGLLAARGL | 411 | Q9NPQ8 | |
| SGGNAGIAAAYAARK | 71 | Q96GA7 | |
| LYGTDGSGTRVGLLN | 286 | Q7Z7B1 | |
| LYGENGTLTAGGLAR | 46 | Q6ZMH5 | |
| IGGGLLEYRASLLAG | 166 | Q8N9L9 | |
| RYFAGNLASGGAAGA | 111 | P12235 | |
| SGTGGAGLLGALSYL | 186 | Q13286 | |
| RSGRLGAGALNAGSY | 391 | O75122 | |
| QLLRIGGGRGGDLYT | 6 | Q9Y242 | |
| GGGQALYIDGDLNRG | 511 | Q9ULP9 | |
| GLLFGSLAGLGAYQL | 41 | Q9P0S9 | |
| GAGLSREAIYNFGGI | 196 | Q5JXA9 | |
| LNGSARTIGAALIGY | 1376 | Q8IZQ1 | |
| ARGRAGYGFTLSGQA | 26 | O14924 | |
| GLGNGGLGRLAACFL | 131 | P11217 | |
| GGLGEGEYAQRLQAL | 2056 | Q15772 | |
| TALAGFDGRLYAIGG | 251 | C9JR72 | |
| GLGNGGLGRLAACFL | 131 | P11216 | |
| AGLLFGSLAGVGAYQ | 41 | A8MWL7 | |
| YIGADGSLRLLLANG | 1761 | Q6N022 | |
| AGLLFGSLAGLGAYQ | 41 | Q9NUH8 | |
| LGYGQAFVGGLALSL | 191 | P0C7Q6 | |
| GQLRAYGAGLLSSIG | 371 | Q8IWU9 | |
| LLLAGGQGTRLGVAY | 106 | Q16222 | |
| LLNALGLAGDYLAQG | 106 | Q9BVC6 | |
| ASLSGIGQELGAGAY | 21 | Q9NZI7 | |
| GGLAGLLGSIVDSYL | 261 | Q96HH6 | |
| GRSNDGAYSLVLAGG | 451 | Q96T88 | |
| LGALAARSGAAYGPG | 316 | Q9H1Z9 | |
| GLGNGGLGRLAACFL | 131 | P06737 | |
| RSGAGVGVLNNLLYA | 486 | O95198 | |
| IHGRGFGSRSLYNLG | 51 | Q7Z794 | |
| GGFGSRSLYSLGGVR | 41 | Q3SY84 |